Meat consumption and risk of esophageal and gastric cancer in a large prospective study.
Abstract | OBJECTIVES: METHODS: RESULTS: Red meat intake was positively associated with esophageal squamous cell carcinoma (HR for the top versus bottom quintile=1.79, 95% CI: 1.07-3.01, P for trend=0.019). Individuals in the highest intake quintile of 2-amino-3,4,8-trimethylimidazo[4,5-f] quinoxaline (DiMeIQx) had an increased risk for gastric cardia cancer (HR=1.44, 95% CI: 1.01-2.07, P for trend=0.104). Furthermore, those in the highest quintile of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine ( PhIP), or heme iron intake had a suggestive increased risk for esophageal adenocarcinoma (HR=1.35, 95% CI: 0.97-1.89, P for trend=0.022; HR=1.45, 95% CI: 0.99-2.12, P for trend=0.463; or HR=1.47, 95% CI: 0.99-2.20, P for trend=0.063, respectively). Benzo[a]pyrene, nitrate, and nitrite were not associated with esophageal or gastric cancer. CONCLUSIONS:
|
Authors | Amanda J Cross, Neal D Freedman, Jiansong Ren, Mary H Ward, Albert R Hollenbeck, Arthur Schatzkin, Rashmi Sinha, Christian C Abnet |
Journal | The American journal of gastroenterology
(Am J Gastroenterol)
Vol. 106
Issue 3
Pg. 432-42
(Mar 2011)
ISSN: 1572-0241 [Electronic] United States |
PMID | 20978481
(Publication Type: Journal Article, Research Support, N.I.H., Intramural)
|
Chemical References |
- Carcinogens
- Mutagens
- Quinoxalines
- 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline
- Iron
|
Topics |
- Adenocarcinoma
(epidemiology, etiology)
- Aged
- Carcinogens
- Carcinoma, Squamous Cell
(epidemiology, etiology)
- Cardia
- Esophageal Neoplasms
(epidemiology, etiology)
- Feeding Behavior
- Female
- Follow-Up Studies
- Humans
- Iron
(adverse effects)
- Male
- Meat
(adverse effects)
- Middle Aged
- Mutagens
- Odds Ratio
- Prospective Studies
- Quinoxalines
(adverse effects)
- Risk Factors
- Stomach Neoplasms
(epidemiology, etiology)
- Surveys and Questionnaires
- United States
(epidemiology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|